How is CM Yogi Adityanath Enhancing the Start-Up Ecosystem in UP?

Synopsis
Key Takeaways
- CM Yogi Adityanath is dedicated to fostering a start-up ecosystem in Uttar Pradesh.
- Four Lucknow-based laboratories are making significant advancements in Ayurveda-based drugs.
- BGR-34 is a key drug that has the potential for diabetes reversal.
- The conclave showcased the increasing global demand for herbal medicine.
- Government support is pivotal for startups looking to enter global markets.
Lucknow, Sep 18 (NationPress) Chief Minister Yogi Adityanath has committed to fostering a robust start-up ecosystem in Uttar Pradesh. He lauded the significant advancements made by four government laboratories located in Lucknow that are extending their reach globally with Ayurveda-based medicines, as stated by an official on Thursday.
While engaging with representatives from research institutions, startups, Ayurveda specialists, and policymakers at the two-day CSIR Startup Conclave, CM Adityanath commended the efforts of four laboratories affiliated with the Council of Scientific and Industrial Research (CSIR) — the National Botanical Research Institute (NBRI), the Central Institute of Medicinal and Aromatic Plants (CIMAP), the Indian Institute of Toxicology Research (IITR), and the Central Drug Research Institute (CDRI).
Collectively, these institutes have introduced 13 significant herbal drugs targeting lifestyle and chronic ailments, including BGR-34 for diabetes, Paclitaxel derived from the bark of the Arjuna tree for blood cancer, and Picroliv for fatty liver and degeneration of liver cells.
BGR-34 captured the most attention at the conclave, as it is a formulation co-developed by NBRI and CIMAP using six herbs: Daruharidra, Giloy, Vijaysar, Gudmar, Manjistha, and Methi. While already acclaimed for managing blood sugar levels, this drug is being positioned as a viable option for long-term diabetes reversal, an area that is gaining focus in global healthcare.
“Globally, the conversation is shifting from diabetes management to diabetes reversal,” remarked Dr. Sanchit Sharma, who oversees the commercial marketing of BGR-34. “Formulations like BGR-34 exemplify the collaboration between Ayurveda and modern science, and such innovations could lay the groundwork for a diabetes-free future,” he added.
The conclave emphasized the increasing potential of India’s herbal medicine sector in both domestic and international markets for policymakers and industry leaders.
During his attendance at the conclave, Union Science and Technology Minister Dr. Jitendra Singh remarked that the initiative showcases the “lab to people” innovation model.
He encouraged startups to utilize technologies developed by the government and expand them into global markets, where the demand for natural and herbal solutions is on the rise. Uttar Pradesh Chief Minister Yogi Adityanath, who toured the exhibition alongside Dr. Singh, also urged researchers to expedite the commercialization of herbal products.